found that through ROS-mediated activation of the PI3K/Akt signaling pathway, HIF-1α was up-regulated in cancer cells, inducing glucose metabolic reprogramming, and eventually cancer cells acquire resistance to anti-tumor drug (108). Here, HIF1A is linked to cancer.